GO:0046628 positive regulation of insulin receptor signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046628 describes any process that increases the frequency, rate or extent of insulin receptor signaling, a central biological process for metabolic control.
• Positive regulation is achieved through phosphorylation and dephosphorylation events, especially on IRS-1, which act as a molecular switch for insulin action.
• Feedback loops, including those involving MT1-MMP-mediated cleavage of the insulin receptor, can downregulate signaling and contribute to age-associated insulin resistance.
• Neuraminidase 1 (NEU1) positively regulates insulin signaling by modulating receptor glycosylation and downstream AKT activation.
• The pathway is conserved across species; in C. elegans, pervasive positive and negative feedback regulation of insulin-like signaling controls metabolism and longevity.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to dissect causal roles of genes that positively regulate insulin receptor signaling [1,4].
Description
The insulin receptor signaling pathway is a fundamental biological process that controls glucose uptake, lipid synthesis, protein metabolism, and cell growth. Positive regulation of this pathway, annotated as GO:0046628, refers to any process that increases the frequency, rate or extent of insulin receptor signaling. This regulation is critical for maintaining metabolic homeostasis, and its dysregulation is a hallmark of insulin resistance, type 2 diabetes, and related metabolic disorders [1,4]. Researchers study positive regulators to identify therapeutic targets that can enhance insulin sensitivity or restore signaling in disease states [4,8]. Understanding these mechanisms requires integrating biochemical, genetic, and cell-based models, including CRISPR-engineered cell lines [1,6].
positive regulation of insulin receptor signaling pathway At A Glance
| GO ID | GO:0046628 |
|---|---|
| GO term | positive regulation of insulin receptor signaling pathway |
| Ontology | biological_process |
| Synonym | activation of insulin receptor signaling pathway; positive regulation of insulin receptor signalling pathway; stimulation of insulin receptor signaling pathway; up regulation of insulin receptor signaling pathway; up-regulation of insulin receptor signaling pathway; upregulation of insulin receptor signaling pathway |
| Major function | Increases the frequency, rate or extent of insulin receptor signaling, thereby enhancing downstream metabolic and growth responses [1,4]. |
| Related processes | Insulin receptor signaling pathway (GO:0008286); positive regulation of glucose import; positive regulation of AKT signaling. |
| Key regulators | IRS-1 phosphorylation status, NEU1, MT1-MMP, feedback loops involving mTOR/S6K [4,6,8]. |
| Disease relevance | Insulin resistance, type 2 diabetes, obesity, aging, and cancer metabolism [1,8]. |
| Research methods | CRISPR knockout/knock-in, phosphoproteomics, glucose uptake assays, Western blot for p-AKT/p-IRS-1 [1,4,6]. |
What Is GO:0046628?
GO:0046628 (positive regulation of insulin receptor signaling pathway) is a biological process term defined as any process that increases the frequency, rate or extent of insulin receptor signaling. In practice, this includes molecular events that enhance insulin receptor activation, amplify downstream phosphorylation cascades (e.g., IRS-1, AKT), or counteract negative feedback mechanisms, thereby boosting the cellular response to insulin [1,4].
Why Is positive regulation of insulin receptor signaling pathway Important in Cell Biology?
Positive regulation of insulin receptor signaling is essential for normal physiology because it ensures robust insulin action in tissues such as muscle, liver, and adipose. When this positive regulation is impaired, cells become insulin resistant, a condition that precedes type 2 diabetes and metabolic syndrome [1,4]. Conversely, excessive positive regulation can contribute to pathological states like cancer, where hyperactive insulin signaling promotes proliferation. Therefore, understanding the molecular players that positively regulate this pathway offers opportunities for therapeutic intervention in metabolic diseases and cancer [4,6].
• Maintains glucose homeostasis by enhancing insulin-stimulated glucose uptake in muscle and fat.
• Controls lipid and protein metabolism through downstream AKT and mTOR signaling [2,3].
• Dysregulation leads to insulin resistance, a hallmark of type 2 diabetes and obesity [1,4].
• Plays a role in aging and longevity, as shown by feedback regulation in C. elegans.
• Modulates cell growth and proliferation, linking to cancer risk when hyperactivated.
• Provides targets for drug discovery aimed at improving insulin sensitivity [4,6].
• Involves post-translational modifications such as phosphorylation and glycosylation that can be targeted [4,6].
• Conserved across species, enabling genetic studies in model organisms.
• Feedback loops (e.g., MT1-MMP cleavage) offer mechanisms for fine-tuning signaling.
• CRISPR screens can identify novel positive regulators for therapeutic development [1,4].
What Happens During positive regulation of insulin receptor signaling pathway?
Insulin binding and receptor activation
In simple terms: Insulin binds to its receptor, turning it on.
The insulin receptor is a tetrameric receptor tyrosine kinase. Upon insulin binding, the receptor undergoes autophosphorylation, which increases its kinase activity and creates docking sites for substrates such as IRS-1. Positive regulation at this stage can involve factors that stabilize the active conformation or enhance ligand binding.
IRS-1 phosphorylation and signal amplification
In simple terms: The receptor adds phosphate groups to IRS-1, which acts as a hub to amplify the signal.
Phosphorylation of IRS-1 on specific tyrosine residues is a critical positive regulatory step. This phosphorylation is mediated by the activated insulin receptor and is opposed by phosphatases. Positive regulation can occur through inhibition of phosphatases or enhancement of kinase activity, leading to increased downstream signaling.
Downstream AKT activation
In simple terms: The signal travels to AKT, which controls many metabolic effects.
Phosphorylated IRS-1 recruits PI3K, leading to PIP3 production and AKT activation. Positive regulators can act at this level by promoting PI3K activity or inhibiting negative regulators like PTEN. AKT then phosphorylates targets that mediate glucose uptake, glycogen synthesis, and protein synthesis [1,4].
Feedback regulation and cross-talk
In simple terms: The pathway has brakes and accelerators that keep it balanced.
Positive regulation is counterbalanced by negative feedback loops. For example, MT1-MMP cleaves the insulin receptor, reducing signaling and contributing to age-associated insulin resistance. In C. elegans, pervasive positive and negative feedback regulates insulin-like signaling, affecting metabolism and lifespan. Understanding these loops is key to manipulating the pathway therapeutically.
Role of glycosylation and NEU1
In simple terms: Sugar modifications on the receptor can boost signaling.
Neuraminidase 1 (NEU1) removes sialic acid residues from the insulin receptor, which enhances its signaling capacity. This positive regulation by NEU1 is important for insulin sensitivity and is a potential therapeutic target.
Key Genes Involved in GO:0046628 positive regulation of insulin receptor signaling pathway
The following genes and proteins are central to positive regulation of insulin receptor signaling, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| INSR | Insulin receptor; initiates signaling upon insulin binding | Mutations cause severe insulin resistance; target for CRISPR knock-in/knockout |
| IRS1 | Docking protein; amplifies signal via tyrosine phosphorylation | Phosphorylation status determines positive vs negative regulation |
| IRS2 | Alternative IRS isoform; important in liver and beta cells | Compensatory signaling; knockout models show diabetes |
| PIK3CA | Catalytic subunit of PI3K; generates PIP3 | Positive regulator; mutations in cancer |
| AKT1 | Serine/threonine kinase; mediates metabolic effects | Key node for positive regulation; phosphorylation readout [1,4] |
| AKT2 | Insulin-responsive AKT isoform | Knockout causes insulin resistance |
| NEU1 | Neuraminidase; removes sialic acid from receptor | Positively regulates insulin signaling |
| MMP14 | MT1-MMP; cleaves insulin receptor | Negative regulator; contributes to aging-related insulin resistance |
| PTPN1 | Protein tyrosine phosphatase 1B; dephosphorylates IR/IRS | Negative regulator; knockout enhances insulin sensitivity |
| PTEN | Lipid phosphatase; opposes PI3K | Negative regulator; loss enhances signaling |
| SLC2A4 | GLUT4 glucose transporter | Downstream effector; translocation is functional readout |
| RPS6KB1 | S6K1; mediates negative feedback on IRS-1 | Feedback regulation |
| TSC2 | Tuberin; integrates insulin signaling with mTOR | Cross-talk with AMPK pathway |
| PRKAA1 | AMPK catalytic subunit; inhibits mTOR and may modulate insulin signaling | Energy sensor; interacts with insulin pathway |
| SIRT1 | Deacetylase; regulates insulin sensitivity | Positive regulator via PGC-1α |
| PPARGC1A | PGC-1α; coactivator of mitochondrial biogenesis | Downstream of insulin/AMPK; affects metabolism |
| LEPR | Leptin receptor; cross-talk with insulin signaling | Integrates energy balance |
| FOXO1 | Transcription factor inhibited by AKT | Mediates insulin effects on gene expression |
How Is positive regulation of insulin receptor signaling pathway Regulated?
Positive regulation of insulin receptor signaling is itself tightly regulated by multiple mechanisms. Phosphorylation of IRS-1 on serine residues often inhibits signaling, providing a negative feedback loop. The mTOR/S6K1 pathway phosphorylates IRS-1 on serine residues, reducing insulin sensitivity. Conversely, phosphatases such as PTP1B remove phosphate groups from the receptor and IRS-1, terminating signaling; inhibition of PTP1B enhances insulin action. In C. elegans, genetic screens have revealed pervasive feedback regulation of insulin-like signaling, with both positive and negative regulators affecting downstream outputs. Additionally, MT1-MMP-mediated cleavage of the insulin receptor provides an irreversible negative regulatory mechanism linked to aging. These layers of regulation ensure that insulin signaling is appropriate to nutritional and metabolic context.
positive regulation of insulin receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| INSR | Type 2 diabetes, insulin resistance | CRISPR knockout in HepG2 or C2C12 cells; knock-in of patient mutations |
| IRS1 | Insulin resistance, diabetes | Point mutation (e.g., Ser->Ala) to block inhibitory phosphorylation |
| NEU1 | Insulin sensitivity, lysosomal storage disorders | Overexpression in 3T3-L1 adipocytes; knockout to test requirement |
| MMP14 | Aging-related insulin resistance | Knockout in aged mouse models; overexpression in cell lines |
| PTPN1 | Diabetes, obesity | Knockout in liver cells; small molecule inhibitors |
Insulin resistance and type 2 diabetes
Impaired positive regulation of insulin receptor signaling is a core feature of insulin resistance, which precedes type 2 diabetes. Reduced IRS-1 tyrosine phosphorylation and increased serine phosphorylation contribute to this defect. Therapeutic strategies aim to enhance positive regulation, for example by inhibiting PTP1B or activating NEU1.
Aging and metabolic decline
Aging is associated with decreased insulin sensitivity, partly due to increased MT1-MMP-mediated cleavage of the insulin receptor. This negative regulation reduces signaling capacity and contributes to age-related metabolic dysfunction. Interventions that preserve receptor integrity may delay metabolic aging.
Cancer metabolism
Hyperactivation of insulin receptor signaling can promote tumor growth and survival. Positive regulators such as PI3K and AKT are frequently mutated or overexpressed in cancers. Understanding positive regulation helps identify targets for cancer therapy, though caution is needed to avoid disrupting metabolic homeostasis.
Obesity and inflammation
Obesity-induced inflammation leads to serine phosphorylation of IRS-1, which impairs positive regulation and contributes to systemic insulin resistance. Anti-inflammatory strategies may restore insulin sensitivity by removing this negative feedback.
From positive regulation of insulin receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate insulin signaling? | CRISPR knockout in insulin-responsive cell line (e.g., HepG2, C2C12) followed by p-AKT Western blot |
| Does a specific phosphorylation site on IRS-1 mediate positive regulation? | Point mutation (e.g., Tyr->Phe) knock-in via CRISPR |
| Does a disease-associated mutation enhance or impair signaling? | Knock-in of patient mutation in INSR or IRS1 |
| Where does a positive regulator localize in the cell? | Tagged knock-in (e.g., GFP) and imaging |
| Can overexpression of a candidate gene boost insulin sensitivity? | Stable overexpression in adipocytes or hepatocytes |
| What genes are essential for insulin signaling in vivo? | CRISPR library screening in mouse models or organoids |
How to Study the positive regulation of insulin receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot | Phosphorylation of IR, IRS-1, AKT | Validation of positive regulation in knockout/overexpression cells [1,4] |
| Phosphoproteomics | Global phosphorylation changes | Discovery of novel regulators |
| Glucose uptake assay | Functional insulin sensitivity | Screening for enhancers of insulin action |
| CRISPR knockout screen | Gene essentiality for signaling | Identification of positive regulators |
| CRISPR activation screen | Gain-of-function effects | Discovery of genes that boost signaling |
| Co-immunoprecipitation | Protein-protein interactions | Mapping of signaling complexes |
| Immunofluorescence | Subcellular localization | Tracking receptor trafficking |
| qRT-PCR | Transcript levels of target genes | Assessing downstream transcriptional responses |
Phosphoproteomics
Mass spectrometry-based phosphoproteomics allows global analysis of tyrosine and serine/threonine phosphorylation events after insulin stimulation. This method can identify novel positive regulators and quantify changes in IRS-1, AKT, and other nodes.
Western blotting for key phospho-proteins
Immunoblotting with antibodies against p-IR, p-IRS-1 (Tyr), p-AKT (Ser473), and total proteins is a standard method to assess positive regulation. It provides semi-quantitative readouts of pathway activation [1,4].
Glucose uptake assays
Functional readout of insulin signaling, glucose uptake can be measured using radioactive 2-deoxyglucose or fluorescent analogs in cell lines. Positive regulators enhance insulin-stimulated uptake.
CRISPR screens
Genome-wide CRISPR knockout or activation screens can identify genes whose loss or gain alters insulin signaling. These screens are powerful for discovering novel positive regulators.
How CRISPR Can Be Used to Study GO:0046628 positive regulation of insulin receptor signaling pathway
Knockout
CRISPR knockout of candidate positive regulators (e.g., NEU1, IRS1) in insulin-responsive cell lines can determine whether they are required for insulin signaling. Loss of function typically reduces p-AKT and glucose uptake, confirming a positive role [1,6].
Point Mutation
Point mutations can be introduced to mimic or block phosphorylation sites. For example, mutating IRS-1 tyrosine residues to phenylalanine prevents docking and impairs positive regulation, while serine-to-alanine mutations may enhance signaling by blocking inhibitory phosphorylation.
Knock-in
Knock-in of disease-associated mutations (e.g., INSR mutations) or tagged versions of proteins allows study of their effects on signaling in a physiological context. This is useful for modeling insulin resistance syndromes.
Overexpression
CRISPR activation (CRISPRa) or stable overexpression can boost levels of a candidate positive regulator, testing whether increased dosage enhances insulin signaling. This approach can identify rate-limiting components.
How EDITGENE Supports positive regulation of insulin receptor signaling pathway Research
Researchers studying positive regulation of insulin receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in enhancing or dampening the pathway. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from gene knockout to precise point mutations and overexpression, supported by bioinformatics and library screening.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of insulin receptor signaling pathway research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| LEP Knockout HEK293 Cell Line | EDJ-KQ506 | Human | 3952 | Details Get a Quote |
| PAK1 Knockout HEK293 Cell Line | EDJ-KQ721 | Human | 5058 | Details Get a Quote |
| SIRT1 Knockout HEK293 Cell Line | EDJ-KQ1128 | Human | 23411 | Details Get a Quote |
| IRS1 Knockout HEK293 Cell Line | EDJ-KQ1190 | Human | 3667 | Details Get a Quote |
| PRKCZ Knockout HEK293 Cell Line | EDJ-KQ1346 | Human | 5590 | Details Get a Quote |
| ADIPOR1 Knockout HEK293 Cell Line | EDJ-KQ1860 | Human | 51094 | Details Get a Quote |
| SORL1 Knockout HEK293 Cell Line | EDJ-KQ3028 | Human | 6653 | Details Get a Quote |
| OSBPL8 Knockout HEK293 Cell Line | EDJ-KQ6826 | Human | 114882 | Details Get a Quote |
| SORBS1 Knockout HEK293 Cell Line | EDJ-KQ7095 | Human | 10580 | Details Get a Quote |
| SNX5 Knockout HEK293 Cell Line | EDJ-KQ8688 | Human | 27131 | Details Get a Quote |
| GKAP1 Knockout HEK293 Cell Line | EDJ-KQ9520 | Human | 80318 | Details Get a Quote |
| ZBTB7B Knockout HEK293 Cell Line | EDJ-KQ10886 | Human | 51043 | Details Get a Quote |
| ERFE Knockout HEK293 Cell Line | EDJ-KQ11321 | Human | 151176 | Details Get a Quote |
| C1QTNF12 Knockout HEK293 Cell Line | EDJ-KQ12601 | Human | 388581 | Details Get a Quote |
| NR1H4 Knockout HEK293 Cell Line | EDJ-KQ13735 | Human | 9971 | Details Get a Quote |
Displaying Records 1 To 15 Of 74 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About positive regulation of insulin receptor signaling pathway
What is GO:0046628?
GO:0046628 is the Gene Ontology term for positive regulation of insulin receptor signaling pathway, defined as any process that increases the frequency, rate or extent of insulin receptor signaling.
What genes are involved in positive regulation of insulin receptor signaling?
Key genes include INSR, IRS1, IRS2, PIK3CA, AKT1, AKT2, NEU1, and others that enhance signaling or counteract negative regulators [1,4,6].
How is insulin receptor signaling positively regulated?
Positive regulation occurs through mechanisms such as tyrosine phosphorylation of IRS-1, removal of inhibitory sialic acid residues by NEU1, and inhibition of phosphatases like PTP1B [4,6].
What diseases are associated with dysregulated insulin receptor signaling?
Dysregulation is linked to type 2 diabetes, insulin resistance, obesity, aging-related metabolic decline, and cancer [1,4,8].
What is the role of IRS-1 phosphorylation in insulin signaling?
Tyrosine phosphorylation of IRS-1 enhances signaling, while serine phosphorylation often inhibits it, making it a critical switch for positive versus negative regulation.
How does NEU1 positively regulate insulin signaling?
NEU1 removes sialic acid from the insulin receptor, which promotes receptor activation and downstream AKT signaling.
Can CRISPR be used to study positive regulators of insulin signaling?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in this pathway [1,4].
What is the role of MT1-MMP in insulin signaling?
MT1-MMP cleaves the insulin receptor, reducing signaling and contributing to age-associated insulin resistance, thus acting as a negative regulator.
How is insulin receptor signaling feedback regulated?
Feedback loops involving mTOR/S6K1 and phosphatases modulate signaling strength, preventing excessive activation [4,5].
What methods are used to measure positive regulation of insulin receptor signaling?
Common methods include Western blot for phospho-AKT, glucose uptake assays, phosphoproteomics, and CRISPR screens [1,4].
Conclusion
Positive regulation of insulin receptor signaling (GO:0046628) is a vital biological process that ensures appropriate cellular responses to insulin. Its dysregulation underlies major metabolic diseases, making it a prime target for therapeutic intervention. By leveraging CRISPR-based models and advanced screening technologies, researchers can uncover novel positive regulators and translate these findings into clinical applications [1,4,6,8].
References
- 1. Boucher J et al.. 2014. Insulin receptor signaling in normal and insulin-resistant states.. Cold Spring Harb Perspect Biol 6(1) PMID: 24384568
- 2. Chen J et al.. 2025. AMPK/SIRT1/PGC-1α Signaling Pathway: Molecular Mechanisms and Targeted Strategies From Energy Homeostasis Regulation to Disease Therapy.. CNS Neurosci Ther 31(11):e70657 PMID: 41268687
- 3. Lin L et al.. 2020. l-Theanine regulates glucose, lipid, and protein metabolism via insulin and AMP-activated protein kinase signaling pathways.. Food Funct 11(2):1798-1809 PMID: 32057039
- 4. Gual P et al.. 2005. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.. Biochimie 87(1):99-109 PMID: 15733744
- 5. Kaplan REW et al.. 2019. Pervasive Positive and Negative Feedback Regulation of Insulin-Like Signaling in Caenorhabditis elegans.. Genetics 211(1):349-361 PMID: 30425043
- 6. Dridi L et al.. 2013. Positive regulation of insulin signaling by neuraminidase 1.. Diabetes 62(7):2338-46 PMID: 23520133
- 7. Myers MG Jr. 2004. Leptin receptor signaling and the regulation of mammalian physiology.. Recent Prog Horm Res 59:287-304 PMID: 14749507
- 8. Guo X et al.. 2022. Regulation of age-associated insulin resistance by MT1-MMP-mediated cleavage of insulin receptor.. Nat Commun 13(1):3749 PMID: 35768470
